
The balance of power among shareholders, management, and boards of directors has been a subject of debate for many years. One area of intense focus has been how institutional shareholders exercise their proxy votes, which Mary Schapiro, Chairman of…
Investor perspectives on public companies

This "Call to Action" is based upon the simple premise that, given the importance of the audit committee’s responsibilities for broadly overseeing the financial statement process, including the work of the external and internal auditors, it is…
Accounting and financial reporting

Members have long recognized the importance of the CEO–lead director relationship and used the March 1, 2011 meeting to examine it in detail. This issue of ViewPoints offers perspectives from Fortune 500 lead directors on the intimate, nuanced…
Board and committee effectiveness

On February 3–4, 2011, members of the Audit Committee Leadership Network (ACLN) met in New York. In one session, members engaged in a dialogue with Daniel L. Goelzer, who is a member of the Public Company Accounting Oversight Board (PCAOB). Mr.…
Corporate and board regulatory matters

On February 3–4, 2011, members of the Audit Committee Leadership Network (ACLN) met in New York. In one session, members addressed the issue of regulatory compliance. This document reflects a summary of the key points that members raised in the…
Corporate and board regulatory matters

Breast Cancer: clear issues in unmet need, access and cost
Cancer Research UK notes, “Worldwide, more than a million women are diagnosed with breast cancer every year, accounting for a tenth of all new cancers and 23% of all female cancer cases.”…

Initiated by the European Healthcare Innovation Leadership Network (“the Network”) and convened by Tapestry Networks, the Type 2 Diabetes Working Group brings together world-class thought leaders and decision-makers from the ranks of medical experts…
Health system readiness / Healthcare

The Breast Cancer Working Group convened for its third meeting on November 11, 2009 in Berlin. Initiated by the European Healthcare Innovation Leadership Network, the Working Group brings together world-class thought leaders and decision makers from…
Health system readiness / Healthcare

Initiated by the European Healthcare Innovation Leadership Network, the Type 2 Diabetes Working Group brings together world-class thought leaders and decision-makers from the ranks of medical experts, regulators, HTA, payers and advisers, patient…
Health system readiness / Healthcare

The LDN brings together a select group of lead directors, presiding directors, and non-executive chairmen of Fortune 500 companies for private discussions about how to improve the performance of their corporations and earn the trust of their…
Boards and General Management